M&A Deal Summary

Bio-Rad Acquires Celsee

On April 9, 2020, Bio-Rad acquired medical products company Celsee

Acquisition Highlights
  • This is Bio-Rad’s 1st transaction in the Medical Products sector.
  • This is Bio-Rad’s 6th transaction in the United States.
  • This is Bio-Rad’s 1st transaction in Michigan.

M&A Deal Summary

Date 2020-04-09
Target Celsee
Sector Medical Products
Buyer(s) Bio-Rad
Deal Type Add-on Acquisition

Target

Celsee

Ann Arbor, Michigan, United States
Celsee, Inc. offers instruments and consumables for the isolation, detection, and analysis of single cells. Celsee was founded in 2011 and is based in Ann Arbor, Michigan.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bio-Rad

Hercules, California, United States

Category Company
Founded 1952
Sector Medical Products
Employees8,000
Revenue 2.7B USD (2023)
DESCRIPTION

Bio-Rad is a developer, manufacturer, and marketer of a broad range of medical tools and services to the life science research and clinical diagnostics markets. Bio-Rad was incorporated in 1952 and is based in Hercules, California.


DEAL STATS #
Overall 7 of 8
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 6 of 6
State (Michigan) 1 of 1
Country (United States) 6 of 6
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-04-02 Bio-Rad Spectroscopy

Philadelphia, Pennsylvania, United States

Bio-Rad Spectroscopy is a leader in spectral data with over 2 million spectra the world's largest collection including IR, Raman, NIR, NMR, MS, and UV-Vis. Their high-quality KnowItAll Spectral Libraries are ideal for the interpretation, identification, verification, and classification of spectra. Bio-Rad’s KnowItAll Informatics System Software offers integrated solutions to analyze and manage multiple types of spectral and chemical data in multiple file and instrument formats. It also includes patented tools not available in other spectroscopy packages as Bio-Rad continues to add spectral intelligence to its software.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-03 Curiosity Diagnostics

Warsaw, Poland

Curiosity Diagnostics is a late-stage, pre-commercial platform company, is in the process of developing a sample-to-answer, rapid diagnostics PCR system for the molecular diagnostics market. Curiosity Diagnostics was founded in 2012 and is based in Warsaw, Poland.

Buy $170M